Literature DB >> 10690791

Epidemiology of pneumococcal infections in the elderly.

J C Butler1, A Schuchat.   

Abstract

The risk of invasive Streptococcus pneumoniae infection (primarily bacteraemia and meningitis) is greatest among the very young and the very old. Persons in certain racial groups, including African-Americans, American Indians, Native Alaskans and Australian Aborigines, are also at increased risk of disease. Other factors that appear to increase the risk of pneumococcal infection are lower socioeconomic status, recent infection with influenza and possibly other viral respiratory tract infections, chronic medical conditions, and immunosuppressive medications. Reported annual incidences of invasive pneumococcal disease among persons aged > or = 65 years in North America and Europe range from 25 to 90 cases/100,000 persons. In the US and Canada, these rates represent between 15,000 and 30,000 cases annually among the elderly. Mortality caused by pneumococcal infections is highest among the elderly, with nearly 1 in 5 cases resulting in death. Worldwide, S. pneumoniae is the leading cause of community-acquired pneumonia requiring hospitalisation. The high fatality rates, as well as recent outbreaks of pneumococcal infection among unvaccinated nursing home residents and the emergence of drug-resistant pneumococcal strains, highlight the importance of preventing invasive infection by vaccination.

Entities:  

Mesh:

Year:  1999        PMID: 10690791     DOI: 10.2165/00002512-199915001-00002

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  59 in total

1.  The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents.

Authors:  S C Redd; G W Rutherford; M A Sande; A R Lifson; W K Hadley; R R Facklam; J S Spika
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

2.  Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people.

Authors:  J E Sisk; A J Moskowitz; W Whang; J D Lin; D S Fedson; A M McBean; J F Plouffe; M S Cetron; J C Butler
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

3.  Geocoding and linking data from population-based surveillance and the US Census to evaluate the impact of median household income on the epidemiology of invasive Streptococcus pneumoniae infections.

Authors:  F M Chen; R F Breiman; M Farley; B Plikaytis; K Deaver; M S Cetron
Journal:  Am J Epidemiol       Date:  1998-12-15       Impact factor: 4.897

4.  A prospective hospital study of the aetiology of community-acquired pneumonia.

Authors:  I Lim; D R Shaw; D P Stanley; R Lumb; G McLennan
Journal:  Med J Aust       Date:  1989-07-17       Impact factor: 7.738

5.  Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G.

Authors:  S Naraqi; G P Kirkpatrick; S Kabins
Journal:  J Pediatr       Date:  1974-11       Impact factor: 4.406

6.  Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94.

Authors:  S V Nielsen; J Henrichsen
Journal:  Epidemiol Infect       Date:  1996-12       Impact factor: 2.451

7.  Community-acquired pneumonia: impact of immune status.

Authors:  L M Mundy; P G Auwaerter; D Oldach; M L Warner; A Burton; E Vance; C A Gaydos; J M Joseph; R Gopalan; R D Moore
Journal:  Am J Respir Crit Care Med       Date:  1995-10       Impact factor: 21.405

8.  Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group.

Authors:  J F Plouffe; R F Breiman; R R Facklam
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272

9.  High incidence rates of invasive pneumococcal disease in the White Mountain Apache population.

Authors:  M M Cortese; M Wolff; J Almeido-Hill; R Reid; J Ketcham; M Santosham
Journal:  Arch Intern Med       Date:  1992-11

10.  Pneumococcal bacteremia in Monroe County, New York.

Authors:  N M Bennett; J Buffington; F M LaForce
Journal:  Am J Public Health       Date:  1992-11       Impact factor: 9.308

View more
  18 in total

Review 1.  Modelling hospital admissions for lower respiratory tract infections in the elderly in England.

Authors:  B Müller-Pebody; N S Crowcroft; M C Zambon; W J Edmunds
Journal:  Epidemiol Infect       Date:  2006-05-26       Impact factor: 2.451

2.  Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea.

Authors:  Min-Joo Choi; Shin-On Kang; Jin-Jeong Oh; Seong-Beom Park; Min-Ja Kim; Hee-Jin Cheong
Journal:  Hum Vaccin Immunother       Date:  2018-07-11       Impact factor: 3.452

3.  Surveillance of invasive Streptococcus pneumoniae infection in the province of Quebec, Canada, from 1996 to 1998: serotype distribution, Antimicrobial susceptibility, and clinical characteristics.

Authors:  L P Jetté; G Delage; L Ringuette; R Allard; P De Wals ; F Lamothe; V Loo
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

4.  A retrospective analysis of hospital discharge records for S. pneumoniae diseases in the elderly population of Florence, Italy, 2010-2012.

Authors:  Angela Bechini; Cristina Taddei; Alessandro Barchielli; Miriam Levi; Emilia Tiscione; Maria Grazia Santini; Fabrizio Niccolini; Maria Teresa Mechi; Donatella Panatto; Daniela Amicizia; Chiara Azzari; Paolo Bonanni; Sara Boccalini
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 5.  Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice.

Authors:  Angel Vila-Corcoles; Olga Ochoa-Gondar
Journal:  Drugs Aging       Date:  2013-05       Impact factor: 3.923

6.  Estimating the burden of hospitalization for pneumococcal pneumonia in a general population aged 50 years or older and implications for vaccination strategies.

Authors:  Emanuele Amodio; Claudio Costantino; Sara Boccalini; Fabio Tramuto; Carmelo M Maida; Francesco Vitale
Journal:  Hum Vaccin Immunother       Date:  2014-02-27       Impact factor: 3.452

Review 7.  Advances in pneumococcal vaccines: what are the advantages for the elderly?

Authors:  Angel Vila-Córcoles
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 8.  Pneumococcal vaccination and revaccination of older adults.

Authors:  Andrew S Artz; William B Ershler; Dan L Longo
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

9.  A cross-sectional study to investigate pneumococcal vaccination in the elderly in a low income county: patient knowledge, awareness, and attitudes of vaccination and prevalence rates by socioeconomic status.

Authors:  Shoukat Ali Baig; Maroof Hassan; Syed Mustajab Ahmed; Wardah Moazzam; Ailya Inayat
Journal:  Hum Vaccin Immunother       Date:  2014-02-04       Impact factor: 3.452

10.  Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection.

Authors:  Frederik W van Ginkel; Jerry R McGhee; James M Watt; Antonio Campos-Torres; Lindsay A Parish; David E Briles
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.